Literature DB >> 4560435

Plasma concentration of levodopa in Parkinsonism before and after inhibition of peripheral decarboxylase.

J L Reid, D B Calne, S D Vakil, J G Allen, C A Davies.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4560435     DOI： 10.1016/0022-510x(72)90021-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN： 0022-510X            Impact factor:   3.181


× No keyword cloud information.
  5 in total

1.  Gout induced by L-dopa and decarboxylase inhibitors.

Authors:  D B Calne; J Fermaglich
Journal:  Postgrad Med J       Date:  1976-04       Impact factor: 2.401

Review 2.  Clinical pharmacokinetics of levodopa in parkinson's disease.

Authors:  J R Bianchine; G M Shaw
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

Review 3.  Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

4.  "On-off" phenomena related to high plasma levodopa.

Authors:  L E Claveria; D B Calne; J G Allen
Journal:  Br Med J       Date:  1973-06-16

5.  Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study.

Authors:  R Katzenschlager; A Evans; A Manson; P N Patsalos; N Ratnaraj; H Watt; L Timmermann; R Van der Giessen; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-12       Impact factor: 10.154
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.